
March 27, 2019
Hilton Vienna Danube Waterfront
Vienna, Austria
ABOUT CHINA FOCUS@EUROPE VIENNA
Since the recent reform of China’s drug approval process, clinical trials and new drug approval in China has speeded up. In 2017 alone, 34 pharma products and 5 biotech products were approved, making a record high in the history. It opened the door for drug development companies around the world to the Chinese market and also ignited license-in interest from Chinese public pharma companies.
China Focus @ Europe Vienna is bringing together investors and pharma leaders from China and healthcare innovators for an exclusive event designed to inspire, educate and foster cross-border investment and collaboration in leading biopharma innovations from around the world. The forum features premier 1-to-1 networking opportunities prior to and during the forum.
Mar 27, 2019 Hilton Vienna Danube Waterfront Vienna, Austria
ATTENDEE DEMOGRAPHICS
at Previous China Focus Events


Attendees
European Countries
%
Executive Level Attendees
Chinese Companies and Investors
One-to-one meetings
Company Presentations
WHAT
TO
EXPECT
AGENDA
Plenary session: Grand Waterfront Hall 1
8:00 – 9:00 | Check-in |
9:00 – 9:10 | Opening Remarks |
9:10 – 9:40 | Keynote: Status and trends of Chinese investment in Europe Csaba Wolf – Business Development Director, Deloitte |
9:40 – 10:30 | PANEL 1: Opportunities and challenges with China-Europe partnership in life science and healthcare Andy Li – Founding Partner, BioSense Global LLC Dong Chen – Director and China head of business development, Jiangsu Hengrui Pharmaceutical Katherine Cohen – Venture Partner, Panacea Venture Olivier Reinhard – VP Head of business development transactions for China and Emerging Markets, Sanofi |
10:30 – 10:40 | Break |
10:40 – 11:10 | Cross-border Camp Talk: Strategic considerations for obtaining patents on your intellectual property assets Daniel J. Nevrivy – Founder, Nevrivy Patent Law Group P.L.L.C. |
11:10 – 12:00 | PANEL 2: European innovations meet China resources Aamir Shahzad – President, European Society for Translational Medicine Dianna Qian – Partner, Pivotal bioVenture Partners China Fei Tian – Principle, Vesalius Biocapital Gottfried Köhler – Chair of Advisory Board, European Society for Translational Medicine James Warr – Associate, Greenhill & Co. |
12:00 – 13:30 | Lunch |
13:30 – 14:20 | PANEL 3: Oversea strategies of Chinese innovative biotech & pharma Tom Du – Medical Partner, Shenzhen Share Capital Jun Bao – President and CEO, Impact Therapeutics Qingping Zeng – President and CEO, Fosun Orinove Ping Cao – VP business development, Henlius Biotech Sara Chen – Head of business development, Genfleet Therapeutics |
14:20 – 15:30 | Company Presentation |
15:30 – 15:40 | Break |
15:40 – 16:10 | Cross-border Camp Talk: Valuation of your licensing asset – deal or no deal Patrik Frei – CEO, Venture Valuation AG |
16:10- 17:00 | PANEL 4: Partnering opportunities with Chinese pharma Echo Hindle-Yang – CEO, MSQ Ventures Qun Dang – VP Global head of business development, Qilu Pharmaceutical John Xu – CEO and co-founder, Jemincare Therapeutics Carlos de Sousa – CEO, Immunicum AB |
18:00 – 20:00 | MyBioGate China Focus Dinner (Separate registration required) |
Download Sample Attendee List from past China Focus events
Download Program from past China Focus events
SPONSORS OF PREVIOUS CHINA FOCUS


MEDIA PARTNERS








INVITED SPEAKERS

Csaba Wolf
Business Development Director
Deloitte

Katherine Cohen
Venture Partner
Panacea Venture

Andy Li
Founding Partner
Biosense Global LLC

Olivier Reinhard
VP, BD&L for China and emerging markets
Sanofi

Ping Cao
VP business development
Henlius Biotech

Dong Chen
Director and China head of business development
Jiangsu Hengrui Pharmaceutical

Jun Bao
President and CEO
Impact Therapeutics

Qun Dang
VP, Global head of business development
Qilu Pharmaceutical

Qingping Zeng
President and CEO
Fosun Orinove

Dianna Qian
Partner
Pivotal bioVenture Partners China

John Xu
CEO and co-founder
Jemincare Therapeutics

Tom Du
Medical Partner
Shenzhen Share Capital

Echo Hindle-Yang
CEO & Founder
MSQ Ventures

Fei Tian
Principle
Vesalius Biocapital

Sara Chen
Head of business development
Genfleet Therapeutics

James Warr
Associate
Greenhill & Co.
Youwen (Allen) Dai
Registratin, Sponsorship and Collaboration (U.S. and Europe)
Xinxin Li
Registration, Group Delegation and Presenting Companies (U.S.)
Han Yan
Hilton Vienna Danube Waterfront
Address:
Handelskai 269, 1020 VIENNA, Austria
TEL: +43-1-72777
FAX: +43-1-72777